NM Genomix adresses the cancer burden in Bulgaria

NM Genomix adresses the cancer burden in Bulgaria

NM Genomix (Bulgaria) and OncoInv (the Netherlands) have joined forces to make multi cancer early detection available in Bulgaria. OncoSeekĀ® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. Starting...
Low-cost detection test for cancer

Low-cost detection test for cancer

Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnostics is vital. As more and curative treatments options are available the earlier cancer is diagnosed...
SeekIn & OncoInv join forces

SeekIn & OncoInv join forces

SeekIn and OncoInv have joined forces to make multi-cancer early detection (MCED) accessible in low- and middle-income countries (LMICs). SeekIn has developed several blood-based solutions to simplify and enhance cancer diagnosis and analysis. This technology can be...